Literature DB >> 19687743

Treatment of arteriovenous malformation of the pancreas: a case report.

Rodica Gincul1, Jérôme Dumortier, Mihai Ciocirlan, Mustapha Adham, Pierre-Edouard Queneau, Thierry Ponchon, Frank Pilleul.   

Abstract

Pancreatic arteriovenous malformation (AVM) is a rare disease, generally asymptomatic, but sometimes complicated by gastrointestinal bleeding or pancreatitis. We report a case of a 55-year-old man presenting with a large pancreatic AVM. The diagnosis was obtained on a computed tomography scan. A treatment by transarterial embolization was carried out successfully. Selective arterial embolization of pancreatic AVM can represent an effective treatment in the first intention.

Entities:  

Mesh:

Year:  2010        PMID: 19687743     DOI: 10.1097/MEG.0b013e32832eb6b9

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Pancreatic arteriovenous malformation.

Authors:  Shu-Cheng Chou; Yi-Ming Shyr; Shin-E Wang
Journal:  J Gastrointest Surg       Date:  2013-05-02       Impact factor: 3.452

2.  Thrombosis of pancreatic arteriovenous malformation induced by diagnostic angiography: case report.

Authors:  Jernej Vidmar; Mirko Omejc; Rok Dežman; Peter Popovič
Journal:  BMC Gastroenterol       Date:  2016-07-11       Impact factor: 3.067

3.  Transcatheter embolization of pancreatic arteriovenous malformation associated with recurrent acute pancreatitis.

Authors:  S Rajesh; Amar Mukund; Vikram Bhatia; Ankur Arora
Journal:  Indian J Radiol Imaging       Date:  2016 Jan-Mar

4.  Acquired Pancreatic Arteriovenous Malformation.

Authors:  A Van Holsbeeck; I Dalle; K Geldof; L Verhaeghe; K Ramboer
Journal:  J Belg Soc Radiol       Date:  2015-09-15       Impact factor: 1.894

Review 5.  Management of pancreatic arteriovenous malformation: Case report and literature review.

Authors:  Wei Wu; Feng-Duo An; Cheng-Lin Piao; Ming-Kun Tan; Zhen-Duo Si; Lan Xin; Na Zhao; Jian-Jun Leng
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.